Skip to main content

Advertisement

Log in

Study of arginine metabolism in medication overuse chronic migraine: possible defect in NO synthesis

  • Original Article
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

Background and aim

The pathogenesis of the pain that occurs in episodic migraine attack is due to the activation of the trigeminal system’s first neuron receptors located on vessel wall. The release from the endothelium of nitric oxide, a product of arginine metabolism, causes vasodilation and stretching of the vascular trigeminal system and promotes pain. It is unknown whether this same metabolic event is involved in the pain accompanying chronic migraine. To understand the possible role of arginine in the pathogenesis of chronic migraine patients, we evaluated the metabolism of arginine in plasma of chronic migraine and control subjects.

Methods

We evaluated the metabolism of arginine in a group of patients affected by chronic migraine. Quantification of arginine, ornithine, citrulline, monomethyl arginine (NMMA), dimethylarginines (ADMA, SDMA), and tyramine was performed by ultra-performance liquid chromatography coupled with a triple quadrupole mass spectrometer.

Results

Chronic migraine patients showed low plasma levels of arginine, significantly elevated levels of ornithine, ADMA, and NMMA whereas the levels of citrulline and SDMA were in the range of controls.

Conclusions

The elevated levels of ADMA and NMMA, inhibitors of nitric oxide synthase, suggest that the metabolism of arginine may be inhibited with a possible reduction of NO release in the circulation of chronic patients. This suggests that the origin of pain may not be related to the vasodilation of trigeminal vascular system that occurs in episodic migraine patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Data availability

The datasets that support the finding of this study are available from the corresponding author on reasonable request.

Code availability

Not applicable.

Abbreviations

ADMA:

NG,NG-Dimethyl-l-arginine

ARG:

L-Arginine

ORN:

L-Ornithine

CIT:

L-Citrulline

CM:

Chronic migraine

CTRL:

Controls

DA:

Dopamine

E:

Adrenalin

5-HT:

Serotonin

MS/MS:

Tandem mass spectrometry

NE:

Norepinephrine

NMMA:

NG-Methyl-l-arginine

NO:

Nitric oxide

PCA:

Principal component analysis

SDMA:

Symmetric dimethylarginine

TAAR:

Trace amine-associated receptor

TYRA:

Tyramine

UPLC:

Ultra-performance liquid chromatography

References

  1. Headache Classification Committee of the International Headache S (2013) The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia Int J Headache 33(9): 629–808

  2. Silberstein SD, Lipton RB, Sliwinski M (1996) Classification of daily and near-daily headaches: field trial of revised IHS criteria. Neurology 47(4):871–875

    Article  CAS  Google Scholar 

  3. Olesen J, Bousser MG, Diener HC, Dodick D, First M, Goadsby PJ, Gobel H, Lainez MJ, Lance JW, Lipton RB, Nappi G, Sakai F, Schoenen J, Silberstein SD, Steiner TJ (2006) New appendix criteria open for a broader concept of chronic migraine. Cephalalgia Int J Headache 26(6):742-6

  4. D'Amico D, Grazzi L, Usai S, Raggi A, Leonardi M, Bussone G (2011) Disability in chronic daily headache: state of the art and future directions. Neurol Sci 32 Suppl 1S71–6.

  5. Katsarava Z, Schneeweiss S, Kurth T, Kroener U, Fritsche G, Eikermann A, Diener HC, Limmroth V (2004) Incidence and predictors for chronicity of headache in patients with episodic migraine. Neurology 62(5):788–790

    Article  CAS  Google Scholar 

  6. Manack AN, Buse DC, Lipton RB (2010) Chronic migraine: epidemiology and disease burden. Curr Pain Headache Rep 15(1):70–78

    Article  Google Scholar 

  7. D’Andrea G, Cananzi AR, Perini F, Alecci M, Zamberlan F, Hasselmark L, Welch KM, (1994) Decreased collagen-induced platelet aggregation and increased platelet arginine levels in migraine: a possible link with the NO pathway. Cephalalgia Int J Headache 14(5):352–6

  8. D’Andrea G, Toldo M, Cortelazzo S, Milone FF (1982) Platelet activity in migraine. Headache 22(5):207–212

    Article  Google Scholar 

  9. Perini F, D’Andrea G, Galloni E, Pignatelli F, Billo G, Alba S, Bussone G, Toso V (2005) Plasma cytokine levels in migraineurs and controls. Headache 45(7):926–931

    Article  Google Scholar 

  10. Edvinsson L, Haanes KA, Warfvinge K, Krause DN (2018) CGRP as the target of new migraine therapies - successful translation from bench to clinic. Nat Rev 14(6):338–350

    CAS  Google Scholar 

  11. Edvinsson L (2017) The trigeminovascular pathway: role of CGRP and CGRP receptors in migraine. Headache 57(Suppl):247–255

    Google Scholar 

  12. Sarchielli P, Alberti A, Codini M, Floridi A, Gallai V, (2000) Nitric oxide metabolites, prostaglandins and trigeminal vasoactive peptides in internal jugular vein blood during spontaneous migraine attacks. Cephalalgia Int J Headache 20(10):907–18

  13. Tsikas D, Wu G (2015) Homoarginine, arginine, and relatives: analysis, metabolism, transport, physiology, and pathology. Amino Acids 47(9):1697–1702

    Article  CAS  Google Scholar 

  14. Flam BR, Eichler DC, Solomonson LP (2007) Endothelial nitric oxide production is tightly coupled to the citrulline-NO cycle. Nitric Oxide 17(3–4):115–121

    Article  CAS  Google Scholar 

  15. Gainetdinov RR, Hoener MC, Berry MD (2018) Trace Amines and Their Receptors. Pharmacol Rev 70(3):549–620

    Article  CAS  Google Scholar 

  16. Koh AHW, Chess-Williams R, Lohning AE (2019) Differential mechanisms of action of the trace amines octopamine, synephrine and tyramine on the porcine coronary and mesenteric artery. Sci Rep 9(1):10925

    Article  Google Scholar 

  17. Grazzi L, Raggi A, D’Amico D, Sansone E, Leonardi M, Andrasik F, Gucciardi A, Guido D, D’Andrea G (2019) A prospective pilot study of the effect on catecholamines of mindfulness training vs pharmacological prophylaxis in patients with chronic migraine and medication overuse headache. Cephalalgia Int J Headache 39(5):655–664

  18. Gray N, Plumb RS, Wilson ID, Nicholson JK (2019) A validated UPLC-MS/MS assay for the quantification of amino acids and biogenic amines in rat urine. J Chromatogr 1106–110750–57

  19. Benjamini Y, Hochberg Y (1995) Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. J R Stat Soc Series B Methodol 57(1): 289–300

  20. Bode-Boger SM, Scalera F, Kielstein JT, Martens-Lobenhoffer J, Breithardt G, Fobker M, Reinecke H (2006) Symmetrical dimethylarginine: a new combined parameter for renal function and extent of coronary artery disease. J Am Soc Nephrol 17(4):1128–1134

    Article  Google Scholar 

  21. D’Andrea G, D’Arrigo A, Dalle Carbonare M, Leon A (2012) Pathogenesis of migraine: role of neuromodulators. Headache 52(7):1155–1163

    Article  Google Scholar 

  22. D’Andrea G, Gucciardi A, Perini F, Leon A (2019) Pathogenesis of Cluster Headache: From Episodic to Chronic Form, the Role of Neurotransmitters and Neuromodulators. Headache 59(9):1665–1670

    Article  Google Scholar 

  23. Borowsky B, Adham N, Jones KA, Raddatz R, Artymyshyn R, Ogozalek KL, Durkin MM, Lakhlani PP, Bonini JA, Pathirana S, Boyle N, Pu X, Kouranova E, Lichtblau H, Ochoa FY, Branchek TA, Gerald C (2001) Trace amines: identification of a family of mammalian G protein-coupled receptors. Proc Natl Acad Sci USA 98(16):8966–8971

    Article  CAS  Google Scholar 

  24. Pradhan AA, Bertels Z, Akerman S (2018) Targeted Nitric Oxide Synthase Inhibitors for Migraine. Neurotherapeutics 15(2):391–401

    Article  CAS  Google Scholar 

  25. D’Andrea G, Gucciardi A, Perini F, Leon A (2019) The role of neurotransmitters and neuromodulators in the pathogenesis of cluster headache: a review. Neurol Sci 40(Suppl 1):39–44

    Article  CAS  Google Scholar 

  26. D’Andrea G, Cevoli S, Colavito D, Leon A (2015) Biochemistry of primary headaches: role of tyrosine and tryptophan metabolism. Neurol Sci 36(Suppl):117–122

    Google Scholar 

Download references

Funding

The research was partially funded by the F.I.CEF Charity (Italian Foundation for Headache, Naples, Italy).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Antonina Gucciardi.

Ethics declarations

Ethics approval

The study was approved by the Ethical Committee of Neurological Institute C. Besta of Milan, Italy, and was performed in accordance with the Helsinki Declaration.

Informed consent

Written informed consent was obtained from each patient prior the onset of the study.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

D’Andrea, G., Gucciardi, A., Giordano, G. et al. Study of arginine metabolism in medication overuse chronic migraine: possible defect in NO synthesis. Neurol Sci 43, 2745–2749 (2022). https://doi.org/10.1007/s10072-021-05672-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-021-05672-7

Keywords

Navigation